Digital Hybrid and multi-cloud: The next step for biotech to secure ... An unmissable trend for those working in biotech research over the past decade has been the transition to cloud computing.
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
